European Medicines Agency (EMA) | What's new Follow Orphan designation: botaretigene sparoparvovec Treatment of inherited retinal dystrophies due to defects in the RPGR gene, 23/07/2025 Positive https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-16-1715 ema.europa.eu
